Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial.

Autor: Klein EM; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany.; Department of Internal Medicine 5, Klinikum Nuremberg, Paracelsus Medical University, 90419 Nuremberg, Germany., Tichy D; Division of Biostatistics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Salwender HJ; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, 22763 Hamburg, Germany., Mai EK; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany., Duerig J; Department of Hematology, University Clinic Essen, 45147 Essen, Germany., Weisel KC; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Bertsch U; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany.; National Center for Tumor Diseases, 69120 Heidelberg, Germany., Akhavanpoor M; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany., Besemer B; Department of Hematology, Oncology and Immunology, University Hospital Tübingen, 72076 Tübingen, Germany., Munder M; Department of Internal Medicine III, University Medical Center Mainz, 55131 Mainz, Germany., Lindemann HW; Department of Hematology and Oncology, Katholisches Krankenhaus Hagen, 58097 Hagen, Germany., Hose D; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany., Seckinger A; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany., Luntz S; Coordination Centre for Clinical Trials (KKS) Heidelberg, 69120 Heidelberg, Germany., Jauch A; Institute of Human Genetics, University of Heidelberg, 69120 Heidelberg, Germany., Elmaagacli A; Department of Hematology and Oncology, Asklepios Hospital Hamburg St. Georg, 20099 Hamburg, Germany., Fuhrmann S; Department of Hematology and Oncology, Helios Hospital Berlin Buch, 13125 Berlin, Germany., Brossart P; Department of Internal Medicine, Oncology, Hematology, Immuno-Oncology and Rheumatology/Clinical Immunology, University Hospital Bonn, 53127 Bonn, Germany., Goerner M; Department of Hematology, Oncology and Palliative Care, Klinikum Bielefeld, 33604 Bielefeld, Germany., Bernhard H; Internal Medicine V, Klinikum Darmstadt, 64283 Darmstadt, Germany., Raab MS; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany., Blau IW; Medical Clinic, Charité University Medicine Berlin, 13353 Berlin, Germany., Haenel M; Department of Internal Medicine III, Klinikum Chemnitz, 09116 Chemnitz, Germany., Scheid C; Department of Internal Medicine I, University Hospital Cologne, 50937 Cologne, Germany., Goldschmidt H; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany.; National Center for Tumor Diseases, 69120 Heidelberg, Germany., On Behalf Of The German-Speaking Myeloma Multicenter Group Gmmg

Publikováno v: Cancers [Cancers (Basel)] 2021 Sep 28; Vol. 13 (19). Date of Electronic Publication: 2021 Sep 28.